Abstract
Repigmentation by body region in patients with vitiligo treated with ruxolitinib cream over 52 weeks.
Full Text
Sign-in/Register to access full text options
Paper version not known
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
More From: Journal of the European Academy of Dermatology and Venereology : JEADV
Paper Title
Journal
Date